1. Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial). (December 2022) Authors: Longo de Oliveira, André Luiz Malavasi; de Oliveira Pereira, Renata Fernanda; Agati, Leandro Barile; Ribeiro, Camilla Moreira; Kawamura Suguiura, Gabrielly Yukimi; Cioni, Claudia Helena; Bermudez, Marilsa; Pirani, Márcia Bermudez; Caffaro, Roberto Augusto; Castelli, Valter; Resende Aguiar, Valéri... Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 28(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗